Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Interest Expenses: 2020-2025

Historic Interest Expenses for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • LifeStance Health's Interest Expenses fell 4801.4% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year decrease of 1979.62%. This contributed to the annual value of $26.5 million for FY2024, which is 2504.71% up from last year.
  • Latest data reveals that LifeStance Health reported Interest Expenses of $2.8 million as of Q3 2025, which was down 4801.4% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, LifeStance Health's Interest Expenses peaked at $23.2 million during Q2 2021, and registered a low of $2.8 million during Q3 2025.
  • Over the past 5 years, LifeStance Health's median Interest Expenses value was $5.2 million (recorded in 2022), while the average stood at $6.1 million.
  • In the last 5 years, LifeStance Health's Interest Expenses soared by 31664.87% in 2021 and then tumbled by 6921.98% in 2022.
  • LifeStance Health's Interest Expenses (Quarter) stood at $3.6 million in 2021, then skyrocketed by 43.39% to $5.2 million in 2022, then rose by 7.11% to $5.5 million in 2023, then skyrocketed by 69.85% to $9.4 million in 2024, then tumbled by 70.05% to $2.8 million in 2025.
  • Its Interest Expenses stands at $2.8 million for Q3 2025, versus $2.9 million for Q2 2025 and $3.1 million for Q1 2025.